- Open Access
Immature rats show ovulatory defects similar to those in adult rats lacking prostaglandin and progesterone actions
© Gaytan et al; licensee BioMed Central Ltd. 2004
- Received: 02 July 2004
- Accepted: 03 September 2004
- Published: 03 September 2004
Gonadotropin-primed immature rats (GPIR) constitute a widely used model for the study of ovulation. Although the equivalence between the ovulatory process in immature and adult rats is generally assumed, the morphological and functional characteristics of ovulation in immature rats have been scarcely considered. We describe herein the morphological aspects of the ovulatory process in GPIR and their response to classical ovulation inhibitors, such as the inhibitor of prostaglandin (PG) synthesis indomethacin (INDO) and a progesterone (P) receptor (PR) antagonist (RU486). Immature Wistar rats were primed with equine chorionic gonadotropin (eCG) at 21, 23 or 25 days of age, injected with human chorionic gonadotropin (hCG) 48 h later, and sacrificed 16 h after hCG treatment, to assess follicle rupture and ovulation. Surprisingly, GPIR showed age-related ovulatory defects close similar to those in adult rats lacking P and PG actions. Rats primed with eCG at 21 or 23 days of age showed abnormally ruptured corpora lutea in which the cumulus-oocyte complex (COC) was trapped or had been released to the ovarian interstitum, invading the ovarian stroma and blood and lymphatic vessels. Supplementation of immature rats with exogenous P and/or PG of the E series did not significantly inhibit abnormal follicle rupture. Otherwise, ovulatory defects were practically absent in rats primed with eCG at 25 days of age. GPIR treated with INDO showed the same ovulatory alterations than vehicle-treated ones, although affecting to a higher proportion of follicles. Blocking P actions with RU486 increased the number of COC trapped inside corpora lutea and decreased ovulation. The presence of ovulatory defects in GPIR, suggests that the capacity of the immature ovary to undergo the coordinate changes leading to effective ovulation is not fully established in Wistar rats primed with eCG before 25 days of age.
- Granulosa Cell
- Follicular Fluid
- Ovarian Surface Epithelium
- Preovulatory Follicle
- Ovarian Stroma
Ovulation, the release of mature oocytes from the ovary, requires proteolytic degradation of the follicle wall, as well as the overlying ovarian tissues. This happens through the expression of a series of critical genes, triggered in a precise temporal and spatial pattern by the preovulatory LH surge [1, 2]. It is worthy to note that, for successful ovulation, follicle rupture has to occur just at the site of the follicle wall facing the ovarian surface, thus allowing release of the cumulus-oocyte complex (COC) to the periovarian space, while preventing proteolytic damage of the perifollicular tissues at the basolateral follicle sides. A large amount of information on the ovulatory process was accumulated during the last century (reviewed in [1–5]), and the involvement of crucial genes such as those encoding cyclooxygenase-2 (COX-2), and progesterone receptor (PR) has been clearly established. However, the mechanisms underlying the spatial targeting of the follicle rupture remain poorly understood. Although mechanical factors are likely involved in stigma formation and rupture , the mechanisms responsible for the specific location of proteolytic breakdown of the theca layers and perifollicular connective tissue at the apex of the follicle are not known. In recent studies [7–9] we have proposed that both prostaglandins (PG) and progesterone (P), classically recognized as essential ovulatory factors [1, 2], play complementary roles in the spatial targeting of follicle rupture. This was supported by detailed morphological studies in cycling rats treated with indomethacin (INDO), a strong inhibitor of PG synthesis, and RU486 (a PR antagonist), showing antiovulatory effects [1, 2, 10–12].
Gonadotropin-primed immature rats (GPIR) constitute a useful model for the study of ovulation. The administration of a single dose of equine chorionic gonadotropin (eCG) to immature animals induces the growth of abundant follicles, that reach preovulatory size in two days. Ovulation is then triggered by a single dose of human chorionic gonadotropin (hCG), thus providing a large number of synchronized ovulatory follicles [13–25]. An additional advantage of this model is the absence of regressing corpora lutea of previous cycles. This is relevant because structural luteolysis, that is temporally coincident with ovulation in cycling rats, also involves tissue remodeling and proteolytic degradation of the extracellular matrix . For these reasons, GPIR (ranging from 21 to 28 days of age, at the time of eCG treatment [13–25]), have been widely used in studies focused on the ovulatory process, and a large amount of the information in this topic is derived from studies in immature rats. However, it should be kept in mind that GPIR constitute a non-physiological model and the possible immaturity of the pathways leading to ovulation cannot be ruled out.
In order to examine further the role of PG and P in follicle rupture and ovulation, we performed detailed morphological analysis of the ovulatory process in inmature rats primed with gonadotropins at different ages. Surprisingly, these animals showed age-related alterations of the follicle rupture similar to those of adult rats lacking PG and P actions. We report herein the morphological alterations of follicle rupture and ovulation in GPIR and the effects of treatment with P and/or PG of the E series, as well as the response of GPIR to PG synthesis inhibition with INDO and to a PR antagonist (RU486), whose inhibitory effects in ovulation are clearly established [1, 2, 8, 13, 14].
Animals and drugs
Wistar female rats bred in the vivarium of the University of Cordoba were used. The day the litters were born was considered as day 0. Litter size was adjusted to 8 pups. The animals were maintained under controlled conditions of light (14L:10D; lights on 0500-1900) and temperature (22°C). The animals had free access to pelleted food and tap water. Experimental procedures were approved by the Cordoba University Ethical Committee for animal experimentation and were conducted in accordance with the European Union guidelines for care and use of experimental animals. Indomethacin (INDO), Progesterone (P), equine chorionic gonadotropin (eCG), human chorionic gonadotropin (hCG) and prostaglandins were purchased from Sigma.(St Louis, MO). The progesterone antagonist RU486 was obtained from Exlegin (Paris, France).
Gonadotropin-priming at different ages
Wistar immature rats were injected sc with 10 IU of eCG at 1700 h at 21, 23 or 25 days of age, and 48 h later were injected sc with 10 IU of hCG, a frequently used schedule [23, 26, 27]. Body weights were in the recommended range [23, 26] (46.0 ± 0.34, 57.0 ± 1.30 and 61.8 ± 1.4 g, mean ± SEM for n = 5). The animals (5 per group) were sacrificed at 0900 h on the day following hCG injection (i.e. at 24, 26 and 28 days of age). The ovaries, including the ovarian bursa, oviducts and periovarian fat pad, were fixed in Bouin-Hollande's fluid for 24 h and processed for paraffin embedding.
Gonadotropin-primed rats treated with prostaglandins and/or progesterone
Immature rats were primed with eCG at 21 days of age and with hCG 48 h later as described above. In addition, these animals were injected with 100 μg of PGE1 or PGE2, 1 mg of P or 1 mg of P plus 100 μg of PG E1 or PGE2 or vehicles (70% ethanol in saline) at 1730 h (30 min after hCG treatment). These dosages were effective, in the same body weight basis, in previous studies in adult rats . The animals (5 per group) were killed at 0900 h on the day after hCG treatment (i.e. at 24 days of age) and the ovaries were processed as described above.
Gonadotropin.primed rats treated with indomethacin or RU486
Immature rats were primed with eCG at 23 days of age and with hCG 48 h later as described in previous experiments. Indomethacin-treated rats received a sc injection of 0.5 mg of INDO or vehicle (olive oil) at 1200 h at 25 days of age. RU486-treated rats were injected sc with 0.5 mg of RU486 or vehicle (olive oil) at 0900 h at 24 and 25 days of age.The animals (5 per group) were killed at 0900 h on the day following hCG injection (i.e. at 26 days of age) and the ovaries were processed as described above.
Histological analysis of follicle rupture and ovulation
The right ovaries were serially sectioned (6 μm) and stained with hematoxylin and eosin. All sections were examined under the microscope. The total number of cumulus-oocyte complexes (COCs) per ovary were counted. The number of COCs trapped inside the corpus luteum, released to the ovarian interstitium, retained in the bursal cavity or found in the oviducts, was recorded. COCs released to the ovarian interstitium were clearly recognizable by the presence of the oocyte in metaphase II and the first polar body, dispersed cumulus and follicular fluid. The total number of COCs per ovary matches the total number of corpora lutea (unruptured or not). In addition to absolute values, the number of COCs in each location was expressed as the percentage with respect to the total number of COCs (or corpora lutea) per ovary, to assess ovulatory efficiency, avoiding variability in the total numbers of corpora lutea among the different groups. Unruptured follicles measuring less than 575 μm in diameter, showing signs of atresia, such as irregularities of the granulosa cell layer, presence of apoptotic granulosa cells, as well as lack of dispersion of the cumulus or resumption of meiosis, were not considered.
Statistical analysis was performed by ANOVA followed by the Student-Newman-Keuls method for multiple comparison among means. Significance was considered at the 0.05 level.
Ovulatory process in immature rats primed at different ages
Number of COCs per ovary in control rats primed with eCG at different ages.
Age (days) at eCG treatment
COCs located in
42.5 ± 8.72
22.5 ± 4.32
3.17 ± 1.47
0.67 ± 0.42
16.2 ± 6.93
58.4 ± 4.74
18.8 ± 0.70
3.20 ± 1.74
2.40 ± 0.51
34.0 ± 6.54
38.6 ± 3.76
0.6 ± 0.60a,b
37.4 ± 3.20
Effects of P and/or PGE treatment
Number of COCs per ovary in rats primed with eCG at 21 days of ages.
COCs located in
35.4 ± 3.52
17.2 ± 1.47
2.6 ± 0.85
0.6 ± 0.24
15.0 ± 2.72
33.2 ± 4.20
11.0 ± 2.42
2.3 ± 1.02
1.2 ± 0.58
19.0 ± 3.40
33.2 ± 1.62
10.2 ± 2.80
0.6 ± 0.39
3.6 ± 2.59
18.8 ± 3.38
45.6 ± 7.77
17.2 ± 2.97
3.4 ± 1.06
5.8 ± 3.10
19.2 ± 5.45
P4 + PGE1
34.6 ± 5.17
14.6 ± 3.37
0.6 ± 0.39
0.8 ± 0.37
18.6 ± 2.82
P4 + PGE2
35.2 ± 6.85
15.6 ± 3.10
0.6 ± 0.39
5.7 ± 2.85
14.2 ± 1.63
Effects of INDO or RU486 treatments
Number of COCs per ovary in rats primed with eCG at 23 days of ages.
COCs located in
39.6 ± 1.60
12.8 ± 1.0
2.6 ± 1.73
1.0 ± 0.62
23.2 ± 1.53
34.4 ± 3.76
19.2 ± 2.55
10.0 ± 1.35a
0.4 ± 0.39
5.0 ± 0.05a
41.8 ± 3.86
22.8 ± 4.80
0.6 ± 0.39b
3.2 ± 0.57a,b
15.2 ± 3.10a,b
Gonadotropin-primed immature rats (GPIR) is a popular model for the study of ovulation. In this model, eCG stimulates the growth of a large cohort of follicles, that reach preovulatory size in about 48 h and are then induced to ovulate by hCG [1, 2, 28]. Early data indicate that the ovulation rate in immature rats was age-dependent, and that the number of ova found in the oviducts increases, although not linearly, with age [29, 30]. However, these early studies do not provide information on the number of ova that were not effectively ovulated, and the marked variability in the rate of ovulation at different ages could be due to differences in the number of recruited growing follicles, in the responsiveness of preovulatory follicles to the ovulatory stimulus or both. In the present study, we evaluated the ovulatory process in immature rats primed with gonadotropins during the 21–25 day-old period, commonly used in studies focused on ovulation [13, 17, 18, 20–23, 25, 26]. In agreement with previous data [29, 30], the proportion of COCs found in the oviducts (i.e. effectively ovulated) increases in parallel to age. Detailed morphological evaluation indicated that ovulation was unsuccessful in 30–60% of preovulatory follicles in rats primed with eCG before 25 days of age. The nearly normal ovulatory process in immature rats primed with eCG at 25 days of age indicates that ovulatory defects were not due to gonadotropin treatment itself, but to ovarian immaturity at earlier ages. The ovulation failure described herein (in rats primed with eCG at 21 or 23 days of age) was not due to decreased recruitment of growing follicles, as indicated by the equivalent numbers of follicles that reach preovulatory size at all ages tested. The data of this study strongly suggest that the relative ovulatory incompetence of young immature rats was due to a defective capacity of preovulatory follicles to undergo the coordinate network of interactions that leads, in reponse to hCG, to COC release to the periovarian space.
Defective ovulation in GPIR was related to abnormal follicle rupture. Whereas some LH-driven morphological changes in preovulatory follicles, such as cumulus expansion, resumption of the meiotic process and initial luteinization were present and showed normal features in GPIR, aberrant follicle ruptures were frequently observed. This was indicated by the presence of COCs released to the ovarian interstitium, and of corpora lutea showing rupture of the theca layers at any site of the follicle wall with release of follicular fluid to the ovarian stroma. The presence of follicle ruptures at the basolateral follicle sides suggests that the mechanisms underlying the spatial targeting of follicle rupture at the apex are not fully established in immature rats primed with eCG before 25 days of age. Almost identical ovulatory defects have been previously reported in INDO-treated adult cycling rats that also show abnormally ruptured follicles and proteolytic degradation of perifollicular tissues [7–9]. Furthermore, INDO-treated GPIR in the present study showed similar morphological alterations of the ovulatory process as vehicle-treated GPIR, even though the drug increased the number of affected follicles. The similarity of the ovulatory alterations found in GPIR and INDO-treated adult rats raises the question of whether the COX-2-prostaglandin pathway is fully established or not in GPIR. In this context, treatment of GPIR with PG of the E series was carried out in order to analyse whether ovulatory defects in GPIR were due to defective PG synthesis. Treatment with prostaglandin E resulted in a decrease in the invasion of the ovarian stroma and blood vessels by follicular fluid and granulosa cells, but ovulation was not improved significantly. In contrast, supplementation with exogenous PG of the E series inhibits abnormal follilce rupture and restores ovulation in INDO-treated adult rats [2, 8, 31]. This suggests that the possible immaturity of the COX-2-prostaglandin pathway in GPIR would be beyond prostaglandin synthesis, in agreement with previous studies reporting normal PG generation in GPIR in response to hCG treatment . Otherwise, recent studies in COX-2 defective mice  indicate that the COX-2-PG pathway is not fully established in immature rodents.
It has been clearly established that activation of PR plays a crucial role in ovulation [10, 11, 33–37]. Accordingly, adult cycling rats treated with PR antagonists  or inhibitors of the P synthesis  during the preovulatory period showed almost complete inhibition of follicular rupture [9, 11, 34]. Noteworthy, the response of GPIR to PR blockage (showing incomplete inhibition of follicle rupture) was similar to that of adult rats lacking both P and PG actions. In this sense, combined treatment of adult rats with RU486 and INDO resulted in follicle rupture in about 25% of preovulatory follicles . Furthermore, some morphological features of the ovulatory process in GPIR, such as the persistence of the ovarian surface epithelium in spite of the degradation of the underlying tissues, was also a characteristic feature of adult rats treated with both INDO and RU486 . However, exogenous P supplementation did not restore ovulation in GPIR, that suggest a defective response of preovulatory follicles to the ovulatory LH-dependent P surge. RU486-treated GPIR showed a significant increase in the number of COCs retained into the bursal cavity. Alterations in the transport of COCs to the oviduct has been previously described in adult rats treated with a PR antagonist , although the existence of a role for P in the COC transport to the oviduct cannot be ascertained from the present data.
The end-point of the complex interaction network leading to follicle rupture and COC release, is the expression/activation of proteolytic enzymes, reponsible for extracellular matrix breakdown [24, 38, 39]. Proteolytic activity has to be closely modulated by protease inhibitors to prevent damage to perifollicular tissues. However, the characterization and regulation of ovarian proteolytic inhibitors has not been completely elucidated. The presence in GPIR of degradation of the ovarian stroma, invasion of blood and lymphatic vessels in abnormally ruptured follicles, strongly suggest that defective ovulation in GPIR was not due to decreased proteolytic activity but due to untargeted proteolysis. This was particularly suggested by the degradation of the ovarian bursa and invasion of the periovarian fat pad by cumulus cells and follicular fluid released at the follicle apex (see Figs. 1G,1H, 3 and 4), permitting, in some cases, escape of the COC to the peritoneal cavity. In this sense, the use of very young immature rats to characterize proteolytic activity regulation during ovulation could provide conflicting data. In this study, we used Wistar rats. The possible existence of slight differences in the age of ovarian maturation among different rat strains cannot be ruled out.
In conclusion, the presence of aberrant ovulations in very young GPIR, closely resembling those in adult rats lacking P and PG actions, strongly suggests that the capacity of the immature ovary to undergo changes leading to effective ovulation is not fully established in Wistar rats primed with eCG before 25 days of age. This should be taken into account when using the GPIR model for studies focused on ovulation.
This work has been subsidized by Grant BFI2002-00485 from the DGI, Spain. The authors are very grateful to J Molina, P Cano and E Tarradas for their technical assistance.
- Tsafriri A, Chun SY, Reich R: Follicular rupture and ovulation. In: The Ovary. Edited by: Adashi EY, Leung PCK. 1993, New York: Raven Press, 228-243.Google Scholar
- Espey LL, Lipner H: Ovulation. In: The physiology of Reproduction. Edited by: Knobil E, Neill JD. 1994, New York: Raven Press, 1: 725-780. 2Google Scholar
- Brännström M, Janson PO: The biochemistry of ovulation. In: Ovarian Endocrinology. Edited by: Hillier SG. 1991, Oxford: Blackwell Scientific Publications, 132-166.Google Scholar
- Robker RL, Russell DL, Yoshioka S, Sharma SC, Lydon JP, O'Malley BW, Espey LL, Richards JS: Ovulation: a multi-gene, multi-step process. Steroids. 2000, 65: 559-570. 10.1016/S0039-128X(00)00114-8.View ArticlePubMedGoogle Scholar
- Ny T, Wahlberg P, Brändström IJM: Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocrinol. 2002, 187: 29-38. 10.1016/S0303-7207(01)00711-0.View ArticlePubMedGoogle Scholar
- Rodbard D: Mechanics of ovulation. J Clin Endocrinol Metab. 1968, 28: 849-861.View ArticlePubMedGoogle Scholar
- Gaytán F, Tarradas E, Morales C, Bellido C, Sánchez-Criado JE: Morphological evidence for uncontrolled proteolytic activity during the ovulatory process in indomethacin-trated rats. Reproduction. 2002, 123: 639-649. 10.1530/rep.0.1230639.View ArticlePubMedGoogle Scholar
- Gaytán F, Tarradas E, Bellido C, Morales C, Sánchez-Criado JE: Prostaglandin E1 inhibits abnormal follicle rupture and restores ovulation in indomethacin-treated rats. Biol Reprod. 2002, 67: 1140-1147.View ArticlePubMedGoogle Scholar
- Gaytán F, Bellido C, Gaytán M, Morales C, Sánchez-Criado JE: Differential effects of RU486 and indomethacin on follicle rupture during the ovulatory process in the rat. Biol Reprod. 2003, 69: 99-105.View ArticlePubMedGoogle Scholar
- Van der Schoot P, Bakker GH, Kljin JG: of the progesterone antagonist RU486 on ovarian activity in the rat. Endocrinology. 1987, 121: 1375-1382.View ArticlePubMedGoogle Scholar
- Sánchez-Criado JE, Bellido C, Galiot F, López FJ, Gaytán F: A posible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat. Biol Reprod. 1990, 42: 877-886.View ArticlePubMedGoogle Scholar
- Reese J, Zhao X, Ma W, Brown N, Maziasz TJ, Dey SK: Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice. Endocrinology. 2001, 142: 3198-3206. 10.1210/en.142.7.3198.PubMedGoogle Scholar
- Mori T, Kohda H, Kinoshita Y, Ezaki Y, Morimoto N, Nishimura T: Inhibition by indomethacin of ovulation induced by human chorionic gonadotrophin in immature rats primed with pregnant mare serum gonadotrophin. J Endocrinol. 1980, 84: 333-341.View ArticlePubMedGoogle Scholar
- Rao IM, Mahesh VB: Role of progesterone in the modulation of the preovulatory surge of gonadotropins and ovulation in the pregnant mare's serum gonadotropin-primed immature rat and the adult rat. Biol Reprod. 1986, 35: 1154-1161.View ArticlePubMedGoogle Scholar
- Butler TA, Zhu C, Mueller RA, Fuller GC, Lemaire WJ, Woessner JF: Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol Reprod. 1991, 44: 1183-1188.View ArticlePubMedGoogle Scholar
- Zhu C, Woessner JF: A tissue inhibitor of metalloproteinases and α-macroglobulins in the ovulating rat ovary: possible regulators of collagen matrix breakdown. Biol Reprod. 1991, 45: 334-342.View ArticlePubMedGoogle Scholar
- Chun SY, Popliker M, Reich R, Tsafriri A: Localization of preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary. Biol Reprod. 1992, 47: 245-253.View ArticlePubMedGoogle Scholar
- Iwamasa J, Shibata S, Tanaka N, Matsuura K, Okamura H: The relationship between ovarian progesterone and proteolytic enzyme activity during ovulation in the gonadotropin-treated immature rat. Biol Reprod. 1992, 46: 309-313.View ArticlePubMedGoogle Scholar
- Mann JS, Kindy MS, Hyde JF, Clark MR, Curry TE: Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production. Biol Reprod. 1993, 48: 1006-1013.View ArticlePubMedGoogle Scholar
- Natraj U, Richards J: Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology. 1993, 133: 761-769. 10.1210/en.133.2.761.PubMedGoogle Scholar
- Liu K, Wahlberg P, Ny T: Coordinated and cell-specific regulation of memebrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matrix metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation. Endocrinology. 1998, 139: 4735-4738. 10.1210/en.139.11.4735.View ArticlePubMedGoogle Scholar
- Cooke RG, Nothnick WB, Komar C, Burns P, Curry TE: Collagenase and gelatinase messenger ribonucleic acid expression and activity during follicular development in the rat ovary. Biol Reprod. 1999, 61: 1309-1316.View ArticlePubMedGoogle Scholar
- Espey LL, Yoshioka S, Russel D, Ujioka T, Vladu B, Skelsey M, Fujii S, Okamura H, Richards JS: Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropin-primed immature rat. Biol Reprod. 2000, 62: 390-397.View ArticlePubMedGoogle Scholar
- Curry TE, Song L, Wheeler SE: Cellular localization of gelatinases and tisssue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol Reprod. 2001, 65: 855-865.View ArticlePubMedGoogle Scholar
- Simpson KS, Komar CM, Curry TE: Localization and expression of tissue inhibior of metalloproteinase-4 in the immature gonadotropin-stimulated and adult rat ovary. Biol Reprod. 2003, 68: 214-221.View ArticlePubMedGoogle Scholar
- Tanaka N, Espey LL, Stacy S, Okamura H: Epostane and indomethacin actions on ovarian kalikrein and plasminogen activator activities during ovulation in the gonadotropin-primed immature rat. Biol Reprod. 1992, 46: 665-670.View ArticlePubMedGoogle Scholar
- Yoshioka S, Fujii S, Richards JS, Espey LL: Gonadotropin-induced expression of pancreatitis-associated protein-III mRNA in the rat ovary at the time of ovulation. J Endocrinol. 2002, 174: 485-492.View ArticlePubMedGoogle Scholar
- Espey LL, Norris C, Forman J, Siler-Khodr T: Effect of indomethacin, cycloheximide, and aminoglutethimide on ovarian steroid and prostanoid levels during ovulation in the gonadotropin-primed immature rat. Prostaglandins. 1989, 38: 531-539. 10.1016/0090-6980(89)90147-0.View ArticlePubMedGoogle Scholar
- Zarrow MX, Wilson ED: The influence of age on superovulation in the immature rat and mouse. Endocrinology. 1961, 69: 851-855.View ArticlePubMedGoogle Scholar
- Zarrow MX, Quinn DL: Superovulation in the immature rat following treatment with SG-induced ovulation. J Endocrinol. 1963, 26: 181-188.View ArticlePubMedGoogle Scholar
- Sogn JH, Curry TEJr, Brännström M, LeMaire WJ, Koos RD, Papkoff H, Janson PO: Inhibition of follicle-stimulating hormone-induced ovulation by indomethacin in the perfused rat ovary. Biol Reprod. 1987, 36: 536-542.View ArticlePubMedGoogle Scholar
- Matsumoto H, Ma W, Smalley W, Trzaskos J, Breyer RM, Dey SK: Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biol Reprod. 2000, 64: 1557-1565.View ArticleGoogle Scholar
- Mori T, Suzuku A, Nishimura T, Kambegawa A: Inhibition of ovulation in immature rats by antiprogesterone antiserum. J Endocrinol. 1977, 73: 185-186.View ArticlePubMedGoogle Scholar
- Snyder B, Beecham G, Schane H: Inhibition of ovulation in rats with epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase. Proc Soc Exp Biol Med. 1984, 176: 238-242.View ArticlePubMedGoogle Scholar
- Hibbert ML, Stouffer RL, Wolf DP, Zelinski-Wooten MB: Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc Natl Acad Sci USA. 1996, 93: 1897-1901. 10.1073/pnas.93.5.1897.PubMed CentralView ArticlePubMedGoogle Scholar
- Uilenbroek JTJ: Hormone concentration and ovulatory response in rats treated with antiprogestagens. J Endocrinol. 1991, 129: 423-429.View ArticlePubMedGoogle Scholar
- Pall M, Mikuni M, Mitsube K, Brännström M: Time-dependent ovulation inhibition of a selective progesterone-receptor antagonist (Org 31710) and effects on ovulatory mediators in the in vitro perfused rat ovary. Biol Reprod. 2000, 63: 1642-1647.View ArticlePubMedGoogle Scholar
- Reich R, Tsafriri A, Mechanic GL: The involvement of collagenase in ovulation in the rat. Endocrinology. 1985, 116: 522-527.View ArticlePubMedGoogle Scholar
- Woessner JF, Butler T, LeMaire WJ, Morioka N, Mukaida T, Zhu C: The role of collagenase in ovulation in the rat. In: Follicular Development and Ovulation Regulation. Edited by: Tsafriri A, Dekel N. 1989, Serono Symposia: Raven Press, 169-178.Google Scholar
This article is published under license to BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.